EyePoint, Inc. (EYPT)
0.43
+0.02
(+6.12%)
USD |
NASDAQ |
Oct 21, 16:00
0.4201
-0.01
(-2.30%)
After-Hours: 20:00
EyePoint Net Income (Annual) : -231.96M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -231.96M |
| December 31, 2024 | -130.87M |
| December 31, 2023 | -70.80M |
| December 31, 2022 | -102.25M |
| December 31, 2021 | -58.42M |
| December 31, 2020 | -45.39M |
| December 31, 2019 | -56.79M |
| December 31, 2018 | -89.44M |
| June 30, 2017 | -18.48M |
| June 30, 2016 | -21.55M |
| Date | Value |
|---|---|
| June 30, 2015 | 6.347M |
| June 30, 2014 | -13.36M |
| June 30, 2013 | -11.90M |
| June 30, 2012 | -24.84M |
| June 30, 2011 | -8.628M |
| June 30, 2010 | 8.753M |
| June 30, 2009 | -2.511M |
| June 30, 2008 | -75.67M |
| June 30, 2007 | -83.52M |
| June 30, 2006 | -45.31M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Ocular Therapeutix, Inc. | -265.94M |
| Corcept Therapeutics, Inc. | 98.17M |
| Eli Lilly & Co. | 20.64B |
| Regeneron Pharmaceuticals, Inc. | 4.505B |
| Nuvation Bio, Inc. | -204.63M |